Our objective was to evaluate effects of levothyroxine ( l-T@ ) supplementation against neurodevelopmental outcomes at @ months of corrected age in very-low-birth-weight ( VLBW ) infants with hypothyroxinemia but without elevated thyroid-stimulating hormone ( TSH ) concentration .